Your browser doesn't support javascript.
loading
Incident hyperkalemia may be an independent therapeutic target in low ejection fraction heart failure patients: insights from the HEAAL study.
Rossignol, P; Dobre, D; Gregory, D; Massaro, J; Kiernan, M; Konstam, M A; Zannad, F.
Afiliação
  • Rossignol P; INSERM, Centre d'Investigations Cliniques-9501, Nancy, France; Université de Lorraine, France; INSERM U1116, Nancy, France. Electronic address: p.rossignol@chu-nancy.fr.
  • Dobre D; INSERM, Centre d'Investigations Cliniques-9501, Nancy, France; Université de Lorraine, France; INSERM U1116, Nancy, France.
  • Gregory D; CardioVascular Clinical Studies, Boston, MA, United States.
  • Massaro J; Boston University School of Public Health, United States.
  • Kiernan M; Tufts Medical Center, Boston, MA, United States.
  • Konstam MA; Tufts Medical Center, Boston, MA, United States.
  • Zannad F; INSERM, Centre d'Investigations Cliniques-9501, Nancy, France; Université de Lorraine, France; INSERM U1116, Nancy, France; CHU Nancy, Pôle de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, France.
Int J Cardiol ; 173(3): 380-7, 2014 May 15.
Article em En | MEDLINE | ID: mdl-24726210
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Volume Sistólico / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Insuficiência Cardíaca / Hiperpotassemia Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Volume Sistólico / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Insuficiência Cardíaca / Hiperpotassemia Idioma: En Ano de publicação: 2014 Tipo de documento: Article